sglt2 inhibitors and glp 1 receptor agonists Use of GLP-1 Among Patients with Type Diabetes: A Nationwide Register-Based Cohort Study Diabetic Agents, From Metformin to

33 , e12953 (2021)

[DOI] [PMC free article] [PubMed] [Google Scholar] 57.Richards JR, Dorand MF, Royal K, Mnajjed L, Paszkowiak M, Simmons WK

Similarly, liraglutide 3.0 mg daily produced significantly greater BMI drops than placebo (35)

J Bone Miner Res 33:975986 [DOI] [PMC free article] [PubMed] [Google Scholar] 38.Shanbhogue VV, Stving RK, Frederiksen KH et al (2017) Bone structural changes after gastric bypass surgery evaluated by HR-pQCT: a two-year longitudinal study

Yet subcutaneous injections of recombinant GLP-1 were a disappointment in patients, falling short of prior results with intravenous GLP-1

Obesity and impaired metabolic health increase risk of COVID-19-Related mortality in young and middle-aged adults to the level observed in older people: The LEOSS registry